期刊文献+

肝素联合前列腺素及复方丹参预防造血干细胞移植术后肝静脉阻塞病的疗效 被引量:1

Efficacy of prostaglandin,heparin and danshen in prevention of hepatic veno-occlusive disease after hematopoietic stem cell transpIantation
下载PDF
导出
摘要 目的探讨肝素联合前列腺素及复方丹参预防白血病患者造血干细胞移植术(HSCT)后肝静脉阻塞病(HVOD)的疗效。方法回顾性分析2005年1月至2012年12月在该科接受HSCT的72例白血病患者HVOD的发生情况及高危因素。其中,异基因造血干细胞移植(Allo-HSCT)45例,自体造血干细胞移植(Auto-HSCT)27例。所有患者均采用肝素联合前列腺素及复方丹参预防HVOD。结果 72例白血病患者中,2例发生HVOD,发生率为2.7%,其中,重型1例,轻型1例。所有患者均未见明显不良反应。结论肝素联合前列腺素及复方丹参预防白血病患者HSCT术后HVOD安全有效,值得临床推广。 Objective To explore the efficacy of prostaglandin combined with heparin and Danshen for the prevention of hepatic veno-occlusive disease(HVOD)after hematopoietic stem cell transplantation(HSCT)in patients with leukemia.Methods The clin-ical data which included incidence and risk factors of HVOD was analyzed in 72 patients with leukemia who received HSCT in our hospital from Jan,2005 to Dec,2012.Among them,45 patients received Allo-HSCT and the others received Auto-HSCT.All pa-tients were treated with prostaglandin combined with heparin and Dansen to prevent HVOD.Results HVOD occurred in 2 cases a-mong 72 patients with leukemia and the incidence was 2.7%,which included one severe case and one mild case.No obvious side effect was observed.Conclusion Combined treatment with prostaglandin,heparin and Danshen is safe and effective for the preven-tion of HVOD after HSCT in patients with leukemia,which can be widely used in clinic.
出处 《重庆医学》 CAS CSCD 北大核心 2014年第13期1540-1542,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81372249) 教育部新世纪优秀人才支持计划基金资助项目(20114433110012) 广东省教育厅科技创新基金资助项目(2012KJCX0025)
关键词 肝静脉闭塞性疾病 造血干细胞移植 前列腺素 肝素 丹参 hepatic veno-occlusive disease hematopoietic stem cell transplantation prostaglandin heparin Danshen
  • 相关文献

参考文献14

  • 1Rybicka M,Krysiak R,Okopiefi B. Veno-occlusive disease of the liver[J]. Wiad Lek,2009,62(1) :42-51.
  • 2Carreras E,Diaz-Beyd M,Rosinol L, et al. The incidence of veno-occlusive disease following allogeneic hematopoi- etic stem cell transplantation has diminished and the out- come improved over the last decade[J]. Biol Blood Mar- row Transplant,2011,17(11) : 1713-1720.
  • 3Helal I,Byzun A,Rerolle JP,et al. Acute renal failure fol- lowing allogeneic hematopoietic cell transplantation: inci- denee,outeome and risk factors[J]. Saudi J Kidney Dis Transpl, 2011,22(3) :437-443.
  • 4Jevtie D, Zecevie Z,Veljkovie D, et al. Veno-oeelusive dis- ease in pediatric patients after hematopoietie stem cell transplantation:relevance of activated coagulation and fi- brinolysis markers and natural anticoagulants[J]. J Pedi- atr Hematol Oneol,2011,33(3) :227-234.
  • 5Iguehi A, Kobayashi R,Kaneda M, et al. Plasma protein C is a useful clinical marker for hepatic veno-oeelusive dis- ease (VOD) in stem cell transplantation[J]. Pediatr Blood Cancer, 2010,54(3) : 437-443.
  • 6Coppell JA,Riehardson PG,Soiffer R,et al. Hepatic veno- oeelusive disease following stem cell transplantation: inci- dence, clinical course,and outcome[J]. Biol Blood Marrow Transplant,2010,16(2) : 157-168.
  • 7Song JS, Seo JJ, Moon HN, et al. Prophylactic low-dose heparin or prostaglandin E1 May prevent severe veno-oe- elusive disease of the liver after allogeneic hematopoietie stem cell transplantation in Korean children[J]. J KoreanMed Sci, 2006,21 (5) : 897-903.
  • 8Cesaro S,Pillon M, Talenti E, et al. A prospective survey on incidence,risk factors and therapy of hepatic veno-oe- elusive disease in children after hematopoietic stem cell transplantation[J]. Haematologiea, 2005, 90 (10) : 1396- 1404.
  • 9冯四洲,韩明哲,张莉,李成文,邱录贵,李洪强,王志强,姜容,严文伟,韩忠朝.供、受者感染乙型肝炎病毒对造血干细胞移植的影响[J].中华血液学杂志,2000,21(8):414-416. 被引量:13
  • 10Coppell JA,Brown SA,Perry DJ. Veno-occlusive disease: cytokines, genetics, and haemostasis[J]. Blood Rev, 2003, 17(2) :63-70.

二级参考文献6

  • 1邵循道(译),西氏内科学.2 第19版(第19版),1995年,274页
  • 2Dreger P, Schmitz N. Allogeneic transplantation of blood stem cells:coming of age? [ J ]. Ann Hematoi, 2001,80 ( 3 ) : 127 - 136.
  • 3Bolinger AM, Zangwill AB, Slattery JT, et al. Target dose adjustment of busulfan in pediatric patients undergoing bone Marrow Transplantation[J]. Bone Marrow Transplant, 2001,28 ( 11 ) : 1013 - 1018.
  • 4Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) [ J]. Blood, 2000,95 (12) :3702 -3709.
  • 5Hanneke M, van der Straaten, Rob F, et al. Relationship between graft-versus-host disease and graft-versus-leukemia in partial T cell-depleted bone marrow transplantation [ J ]. Br J Heamotol, 2001,114:32 -35.
  • 6Ringden O, Labopin M, Bacigalupo A, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastie leukemia[ J]. J Clin Oneol,2002,20 (24) :4655 - 4664.

共引文献15

同被引文献16

  • 1付丹晖,陈鑫基,杨婷,黄美娟,许贞书,卓光生,陈志哲.异基因外周造血干细胞移植预处理相关并发症[J].福建医科大学学报,2004,38(4):399-400. 被引量:3
  • 2练英莲.层流病房管理标准化的研究[J].中华医院感染学杂志,2004,14(3):303-305. 被引量:10
  • 3江倩,黄晓军,陈欢,许兰平,刘代红,陈育红,张耀臣,刘开彦,郭乃榄,陆道培.异基因造血干细胞移植后重症胃肠道出血15例分析[J].中华血液学杂志,2005,26(5):277-280. 被引量:10
  • 4陶慧清,陈燕华,王惠珍.全环境保护的研究进展[J].南方护理学报,2005,12(5):15-17. 被引量:42
  • 5Perry D. Psychological and social preparation for bone mar- row transplantation [ J ]. Work Health Care, 2000,30 (4) : 71 -92.
  • 6Adelstein KE,Anderson JG,Taylor AG. Importance of meaning -making for patients undergoing hematopoietic stem cell transplantation [ J ]. Oncol Nuts Forum, 2014,41 ( 2 ) : 172 - 184.
  • 7Qiao J,Fu J,Fang T, et al. Evaluation of the effects of pre- conditioning regimens on hepatic veno - occlusive disease in mice after hematopoietic stem cell transplantation [ J ]. Exp Mol Pathol,2015,98( 1 ) :73 -78.
  • 8Bhatt VR, Balasetti V, Abduall JJ, et al. Central Nervous System Complications and Outcomes After Allogeneic Hem- atopoietic Stem Cell Transplantation [ J ]. Clin Lymphoma Myeloma Leuk,2015 (19) :2152 - 2650.
  • 9Ferreira B, Motta Silveira FM, Orange FA. Low - level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic stem cell transplantation: a randomized clinical trial [ J ]. Support Care Cancer, 2016,24 ( 3 ) : 1035 - 1042.
  • 10Shokouhi S,Bray S, Bakhtiyari S, et al. Effects of aGVHD and cGVHD on Survival Rate in Patients with Acute Myeloid Leu- kemia after Mlogeneic Stem Cell Transplantation[ J ]. Int J He- matol Oncol Stem Cell Res,2015,19(3) :112 -121.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部